Novartis

BEOVU

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Novartis

Beovu HCPCS:

J0179

HCPCS Code Descriptor:

Injection, brolucizumab-dbll, 1 mg

Category:

J Code

Beovu NDCs:

00078-0827-60

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Intraocular

Beovu CPT Codes:

Potential CPT administration codes for Beovu can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Beovu:

BEOVU is an Opthalmic drug manufactured by Novartis and administered via the Intraocular route of administration. The J Code: J0179 is aligned to the drug BEOVU.

ACCESS PRICING AND MORE BY REGISTERING

J0179 Added Date:

January 1, 2020

J0179 Effective Date:

January 1, 2020

J0179 Termination Date:

HCPCS Active

Beovu billing and coding information can be found through Novartis at the link below:
Beovu patient assistance information can be found through Good Days at the URL: https://www.mygooddays.org/
BEOVU prescribing information can be found at the link below:
Information regarding BEOVU’s side effects can be found at MedlinePlus